Price (delayed)
$56.24
Market cap
$2.53B
P/E Ratio
432.62
Dividend/share
N/A
EPS
$0.13
Enterprise value
$2.81B
Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of
There are no recent dividends present for OMCL.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.